ArticleJournal of clinical haematology2025

Repurposing Nilotinib as a Selective P38β Inhibitor in Hematopoietic Malignancies: Clinical Evidence and Mechanistic Insights.

Xu Hannah Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.